Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
Emerging Infectious Diseases · 2024
DOI: 10.3201/eid3011.231393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2024. Verfasst von Alex-Mikael Barkoff und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Bordetella pertussis, Whooping Cough, Virulence Factors, Bordetella, Bacterial Outer Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Barkoff, A. M., Kastrin, T., Seme, K., Vitek, M. G., Mertsola, J., & He, Q. (2024). Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia. Emerging Infectious Diseases. https://doi.org/10.3201/eid3011.231393
Vancouver
Barkoff AM, Kastrin T, Seme K, Vitek MG, Mertsola J, He Q. Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia. Emerging Infectious Diseases. 2024. doi:10.3201/eid3011.231393
BibTeX
@article{Barkoff2024,
author = {Barkoff, Alex-Mikael and Kastrin, Tamara and Seme, Katja and Vitek, Marta Grgič and Mertsola, Jussi and He, Qiushui},
title = {Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia},
journal = {Emerging Infectious Diseases},
year = {2024},
doi = {10.3201/eid3011.231393}
}
EUVIMED